+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2020 Update

FEATURED COMPANIES

  • DexCom Inc
  • Eli Lilly and Co
  • Insulet Corp
  • Medtronic MiniMed Inc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Australia, Italy, New Zealand, and other Scandinavia regions (Sweden, Norway and Denmark). Tandem is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • DexCom Inc
  • Eli Lilly and Co
  • Insulet Corp
  • Medtronic MiniMed Inc
Tandem Diabetes Care Inc Company Overview
  • Tandem Diabetes Care Inc Company Snapshot
  • Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Tandem Diabetes Care Inc - Pipeline Analysis Overview
  • Tandem Diabetes Care Inc - Key Facts
  • Tandem Diabetes Care Inc - Major Products and Services
  • Tandem Diabetes Care Inc Pipeline Products by Development Stage
Tandem Diabetes Care Inc Pipeline Products Overview
  • AutoSoft XC
  • AutoSoft XC Product Overview
  • Next Generation Gswim
  • Next Generation Gswim Product Overview
  • t:connect Mobile - Biometric Authentication
  • t:connect Mobile - Biometric Authentication Product Overview
  • t:connect Mobile - Decision Support
  • t:connect Mobile - Decision Support Product Overview
  • t:connect Mobile - Health App Integration
  • t:connect Mobile - Health App Integration Product Overview
  • t:connect Mobile - Mobile Bolus
  • t:connect Mobile - Mobile Bolus Product Overview
  • t:sport
  • t:sport Product Overview
Tandem Diabetes Care Inc - Key Competitors

Tandem Diabetes Care Inc - Key Employees

Tandem Diabetes Care Inc - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Tandem Diabetes Care Inc, Recent Developments
  • Mar 02, 2020: Tandem Diabetes Care announces FDA designation of Basal-IQ technology as an interoperable automated glycemic controller
  • Feb 20, 2020: Data presented at International Diabetes Conference further demonstrate benefits of Tandem Diabetes care automated insulin delivery technologies
  • Feb 05, 2020: Tandem Diabetes Care recalls t:slim X2 insulin pump
  • Jan 15, 2020: Tandem Diabetes Care announces commercial launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States
  • Jan 09, 2020: Tandem Diabetes Care appoints new executive vice president of strategy and corporate development
  • Jan 02, 2020: FDA approves UVA-developed artificial pancreas
  • Dec 23, 2019: Dexcom Partners with Tandem Diabetes Care on the t:slim X2 insulin pump in the UK, Sweden, Italy and Spain
  • Dec 13, 2019: Tandem Diabetes Care announces FDA clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
  • Dec 13, 2019: FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system
  • Nov 20, 2019: Tandem Diabetes Care announces Health Canada approval of t:slim X2 Insulin Pump with Basal-IQ predictive low-glucose suspend technology
Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Tandem Diabetes Care Inc Pipeline Products by Equipment Type
  • Tandem Diabetes Care Inc Pipeline Products by Indication
  • Tandem Diabetes Care Inc, Key Facts
  • Tandem Diabetes Care Inc, Major Products and Services
  • Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage
  • Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage
  • AutoSoft XC - Product Status
  • AutoSoft XC - Product Description
  • Next Generation Gswim - Product Status
  • Next Generation Gswim - Product Description
  • t:connect Mobile - Biometric Authentication - Product Status
  • t:connect Mobile - Biometric Authentication - Product Description
  • t:connect Mobile - Decision Support - Product Status
  • t:connect Mobile - Decision Support - Product Description
  • t:connect Mobile - Health App Integration - Product Status
  • t:connect Mobile - Health App Integration - Product Description
  • t:connect Mobile - Mobile Bolus - Product Status
  • t:connect Mobile - Mobile Bolus - Product Description
  • t:sport - Product Status
  • t:sport - Product Description
  • Tandem Diabetes Care Inc, Key Employees
  • Tandem Diabetes Care Inc, Subsidiaries
  • Glossary
List of Figures
  • Tandem Diabetes Care Inc Pipeline Products by Equipment Type
  • Tandem Diabetes Care Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
  • DexCom Inc
  • Medtronic MiniMed Inc
  • Insulet Corp
  • Solara Medical Supplies, Inc.
  • Eli Lilly and Co
Note: Product cover images may vary from those shown
Adroll
adroll